XBiotech's flu-COVID-19 therapeutic cocktail shows effective anti-virus activity

 

• XBiotech (NASDAQ:XBIT) announces new data for its candidate therapy for treating infections of influenza and COVID-19. The Company continues to analyze components of its FLUVID therapy.
• The True Human antibodies targeting the virus causing COVID-19 were found to effectively neutralize a test virus about four-times better than the antibodies the FDA is now considering for emergency use authorization.
• Ongoing research has also found that the True Human antibodies in this therapeutic cocktail are capable of rescuing 100% of animals that receive an otherwise lethal dose of flu virus.
• The latest research findings suggest the FLUVID therapy, could provide effective therapy for treating complex infections from one or more of these viruses.
• There is no other therapy available to treat both COVID-19 and Influenza infections that occur together.
• https://seekingalpha.com/news/3637928-xbiotechs-influenza-covidminus-19-therapeutic-cocktail-shows-effective-anti-virus-activity